What is Vitality Biopharma Inc (VBIO) stock price today?

Vitality Biopharma Inc (VBIO) currently trades at $0.98 per share. The stock has a market capitalization of $19.77M and a P/E ratio of —x.

Is VBIO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Vitality Biopharma Inc has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Vitality Biopharma Inc's revenue and earnings?

Vitality Biopharma Inc has trailing twelve-month (TTM) revenue of $258290.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.03.

VBIO

Vitality Biopharma Inc

PINK: VBIO · HEALTHCARE · BIOTECHNOLOGY

$0.98

+2.06% today

Updated 2026-04-30

Market cap

$19.77M

P/E ratio

—

P/S ratio

8.04x

EPS (TTM)

$-0.03

Dividend yield

—

52W range

$0 – $0

Volume

0.3M

Market cap

$19.77M

P/E ratio

—

P/S ratio

8.04x

EPS (TTM)

$-0.03

Dividend yield

—

52W range

$0 – $0

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$10.40

+961.44%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-383011.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2018	2019	2020	2021	TTM
Revenue	$102419.00	$258288.00	$0.00	$0.00	$258290.00
Net income	$-4.31M	$-13.12M	$-4.37M	$-880851.00	$-504358.00
EPS	—	—	—	—	$-0.03
Free cash flow	$-2.89M	$-3.67M	$-3.59M	$-1.61M	$-383011.00
Profit margin	-4,207.22%	-5,080.21%	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VBIO	$19.77M	16	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Vitality Biopharma Inc trades at $0.98. Our Smart Value Score of 16/100 indicates the stock is weak. TTM revenue stands at $258290.00.

Frequently asked questions

What is Vitality Biopharma Inc's stock price?

Vitality Biopharma Inc (VBIO) trades at $0.98.

Is Vitality Biopharma Inc overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Vitality Biopharma Inc (VBIO)?

The analyst target price is $10.40, representing +961.4% upside from the current price of $0.98.

What is Vitality Biopharma Inc's revenue?

TTM revenue is $258290.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangePINK

CurrencyUSD

Quick metrics

P/S ratio8.04x

ROE-156.10%

Beta4.11

50D MA$0.38

200D MA$0.26

Shares out0.05B

Float0.03B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VBIO vs LLY →VBIO vs JNJ →VBIO vs ABBV →Stock screener →